$16.64
-0.540 (-3.14%)
At Close: Jun 03, 2026
inTEST Closes Acquisition of Acculogic
09:15pm, Tuesday, 21'st Dec 2021 Business Wire
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American:INTT) Closes Acquisition of Acculogic
inTEST gains on deal to acquire Acculogic for ~US$9M
10:21pm, Thursday, 09'th Dec 2021 Seeking AlphainTEST to Add Electronic Circuit and Electric Vehicle Battery Testing Capabilities with Planned Acquisition of Acculogic Inc.
09:15pm, Thursday, 09'th Dec 2021 Business Wire
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American: INTT) to Add Electronic Circuit and Electric Vehicle Battery Testing Capabilities with Planned Acquisition of Acculogic Inc
State Street Corp Acquires New Position in inTEST Co. (NYSEAMERICAN:INTT)
09:10am, Tuesday, 07'th Dec 2021 Dakota Financial News
State Street Corp acquired a new stake in shares of inTEST Co. (NYSEAMERICAN:INTT) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 28,042 shares of the semiconductor companys stock, valued at approximately $470,000. A number of other hedge funds have also recently made changes to []
inTEST Co. (NYSEAMERICAN:INTT) Short Interest Up 36.7% in November
01:06pm, Thursday, 02'nd Dec 2021 Transcript Daily
inTEST Co. (NYSEAMERICAN:INTT) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 90,900 shares, an increase of 36.7% from the October 31st total of 66,500 shares. Currently, 1.0% of the companys stock are short sold. Based on an average trading volume of 83,600 []
inTEST (NYSEAMERICAN:INTT) Releases Q4 2021 Earnings Guidance
10:48pm, Friday, 19'th Nov 2021 Transcript Daily
inTEST (NYSEAMERICAN:INTT) issued an update on its fourth quarter 2021 earnings guidance on Friday morning. The company provided EPS guidance of $0.140-$0.180 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.180. The company issued revenue guidance of $21.50 million-$22.50 million, compared to the consensus revenue estimate of $20.38 million. Shares of []
Traders Buy High Volume of Call Options on inTEST (NYSEAMERICAN:INTT)
12:30am, Wednesday, 17'th Nov 2021 Transcript Daily
inTEST Co. (NYSEAMERICAN:INTT) saw some unusual options trading activity on Tuesday. Investors bought 3,041 call options on the company. This represents an increase of 1,658% compared to the typical daily volume of 173 call options. Hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. bought a new []
inTEST (NYSEAMERICAN:INTT) Updates Q4 2021 Earnings Guidance
01:34pm, Sunday, 14'th Nov 2021 Transcript Daily
inTEST (NYSEAMERICAN:INTT) issued an update on its fourth quarter 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $0.140-$0.180 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.180. The company issued revenue guidance of $21.50 million-$22.50 million, compared to the consensus revenue estimate of []
inTEST Announces Participation in Upcoming Investor Conferences
08:30am, Thursday, 11'th Nov 2021
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American: INTT) Announces Participation in Upcoming Investor Conferences
inTEST Corporation (INTT) CEO Nick Grant on Q3 2021 Results - Earnings Call Transcript
03:13pm, Friday, 05'th Nov 2021
inTEST Corporation (INTT) CEO Nick Grant on Q3 2021 Results - Earnings Call Transcript
The Top 7 Micro-Cap Stocks to Buy Before 2022
08:50am, Thursday, 04'th Nov 2021
Micro-cap stocks offer big growth potential, but not all opportunities are created equal. Each of these earns a Portfolio Grader “A” rating.
inTEST Announces Third Quarter 2021 Financial Results Conference Call and Webcast
04:15pm, Thursday, 21'st Oct 2021
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American: INTT) Announces Third Quarter 2021 Financial Results Conference Call and Webcast
inTest Enters Medical Cold Chain Market Through Acquisition of Assets of Z-Sciences Corp.
06:30am, Thursday, 07'th Oct 2021
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American: INTT) Enters Medical Cold Chain Market through Acquisition of Assets of Z-Sciences Corp.
inTEST Names Richard Rogoff Vice President of Corporate Development
08:35am, Wednesday, 29'th Sep 2021
MT. LAUREL, N.J.--(BUSINESS WIRE)--inTEST (NYSE American: INTT) Names Richard Rogoff Vice President of Corporate Development
inTEST to Present at Investor Conferences
09:11am, Thursday, 02'nd Sep 2021
MT. LAUREL, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a
Sign In
Buy INTT